Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Codacci-Pisanelli

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 7, 1999
Activity of ruboxyl, a nitroxyl derivative of daunorubicin, on experimental models of colorectal cancer metastasesI Sirovich, N Konovalova, G Codacci-Pisanelli, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1991
5-Fluorouracil (FU) and mitomycin C (MMC) in the management of colorectal carcinoma. Part II. In vitro activity of the two drugs in short-term tumor culturesF Franchi, C Barone, P Seminara, et al.
BJU International|March 11, 2004
Intravesical administration of gemcitabine in superficial bladder cancer: a phase I study with pharmacodynamic evaluationE De Berardinis, G Antonini, G J Peters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1997
Modulation of 5-fluorouracil in mice using uridine diphosphoglucoseG Codacci-Pisanelli, J Kralovanszky, C L van der Wilt, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1995
Thymidylate synthase and drug resistanceG J Peters, C L van der Wilt, B van Triest, et al.
Journal of Chemotherapy (Florence, Italy)|July 26, 2005
Pharmacokinetics of bolus 5-fluorouracil: relationship between dose, plasma concentrations, area-under-the-curve and toxicityG Codacci-Pisanelli, H M Pinedo, J Lankelma, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Antitumour activity, toxicity and inhibition of thymidylate synthase of prolonged administration of 5-fluorouracil in miceG Codacci-Pisanelli, C L van der Wilt, H M Pinedo, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Intermittent continuous infusion of 5-fluorouracil and low dose oral leucovorin in patients with gastrointestinal cancer: relationship between plasma concentrations and clinical parametersR L Poorter, G J Peters, P J Bakker, et al.
Biochimica Et Biophysica Acta|June 27, 2002
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanismG J Peters, H H J Backus, S Freemantle, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 7, 1999
Activity of ruboxyl, a nitroxyl derivative of daunorubicin, on experimental models of colorectal cancer metastasesI Sirovich, N Konovalova, G Codacci-Pisanelli, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1991
5-Fluorouracil (FU) and mitomycin C (MMC) in the management of colorectal carcinoma. Part II. In vitro activity of the two drugs in short-term tumor culturesF Franchi, C Barone, P Seminara, et al.
BJU International|March 11, 2004
Intravesical administration of gemcitabine in superficial bladder cancer: a phase I study with pharmacodynamic evaluationE De Berardinis, G Antonini, G J Peters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1997
Modulation of 5-fluorouracil in mice using uridine diphosphoglucoseG Codacci-Pisanelli, J Kralovanszky, C L van der Wilt, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1995
Thymidylate synthase and drug resistanceG J Peters, C L van der Wilt, B van Triest, et al.
Journal of Chemotherapy (Florence, Italy)|July 26, 2005
Pharmacokinetics of bolus 5-fluorouracil: relationship between dose, plasma concentrations, area-under-the-curve and toxicityG Codacci-Pisanelli, H M Pinedo, J Lankelma, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Antitumour activity, toxicity and inhibition of thymidylate synthase of prolonged administration of 5-fluorouracil in miceG Codacci-Pisanelli, C L van der Wilt, H M Pinedo, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Intermittent continuous infusion of 5-fluorouracil and low dose oral leucovorin in patients with gastrointestinal cancer: relationship between plasma concentrations and clinical parametersR L Poorter, G J Peters, P J Bakker, et al.
Biochimica Et Biophysica Acta|June 27, 2002
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanismG J Peters, H H J Backus, S Freemantle, et al.
Pageof 2